Independent prognostic factors for distant metastases and survival in patients with primary uveal melanoma

European Journal of Cancer

Volumn 40, Issue 16, 2004, Pages 2389-2395

  Schmittel, Alexander ^a   Bechrakis, Nikolaos E ^b   Martus, Peter ^a   Mutlu, Dominic ^a   Scheibenbogen, Carmen ^a   Bornfeld, Norbert ^c   Foerster, Michael H ^b   Thiel, Eckhard ^a   Keilholz, Ulrich ^a  

^a Char Camp Benjamin Franklin H ^*  (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Metastases; Prognostic factors; Survival; Uveal melanoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CILIARY BODY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME; UVEA MELANOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; UVEAL NEOPLASMS;

EID: 7044251629     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.06.028     Document Type: Article

References (25)

1. K.M. Egan, J.M. Seddon, R.J. Glynn, E.S. Gragoudas, and D.M. Albert Epidemiologic aspects of uveal melanoma Surv. Ophthalmol. 32 1988 239 251
2. M. Diener-West, B.S. Hawkins, J.A. Markowitz, and A.P. Schachat A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988 Arch. Ophthalmol. 110 1992 245 250
3. J.A. Shields, C.L. Shields, and L.A. Donoso Management of posterior uveal melanoma Surv. Ophthalmol. 36 1991 161 195
4. A.Y. Bedikian, S.S. Legha, and G. Mavligit Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors Cancer 76 1995 1665 1670
5. E.S. Gragoudas, K.M. Egan, and J.M. Seddon Survival of patients with metastases from uveal melanoma Ophthalmology 98 1991 383 389
6. R. Kath, J. Hayungs, N. Bornfeld, W. Sauerwein, K. Hoffken, and S. Seeber Prognosis and treatment of disseminated uveal melanoma Cancer 72 1993 2219 2223
7. J.M. Seddon, D.M. Albert, P.T. Lavin, and N. Robinson A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma Arch. Ophthalmol. 101 1983 1894 1899
8. C.M. Mooy, and P.T. De Jong Prognostic parameters in uveal melanoma: a review Surv. Ophthalmol. 41 1996 215 228
9. H.F. Shammas, and F.C. Blodi Prognostic factors in choroidal and ciliary body melanomas Arch. Ophthalmol. 95 1977 63 69
10. J.J. Augsburger, Z.M. Correa, J. Freire, and L.W. Brady Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy Ophthalmology 105 1998 1670 1678
11. E. Egger, A. Schalenbourg, and L. Zografos Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma Int. J. Radiat. Oncol. Biol. Phys. 51 2001 138 147
12. P.K. Lommatzsch, C. Werschnik, and E. Schuster Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma Graefes Arch. Clin. Exp. Ophthalmol. 238 2000 129 137
13. M. Diener-West, J.D. Earle, and S.L. Fine Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18 Arch. Ophthalmol. 119 2001 969 982
14. E. Jager, M. Ringhoffer, and H.P. Dienes Granulocyte-macrophage-colony- stimulating factor enhances immune responses to melanoma-associated peptides in vivo Int. J. Cancer 67 1996 54 62
15. M. Marchand, N. van Baren, and P. Weynants Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1 Int. J. Cancer 80 1999 219 230
16. C. Scheibenbogen, D. Nagorsen, and B. Seliger Long-term freedom from recurrence in 2 stage IV melanoma patients following vaccination with tyrosinase peptides Int. J. Cancer 99 2002 403 408
17. C. Scheibenbogen, D. Schadendorf, and N.E. Bechrakis Effects of granulocyte-macrophage colony-stimulating factor and foreign helper protein as immunologic adjuvants on the T-cell response to vaccination with tyrosinase peptides Int. J. Cancer 104 2003 188 194
18. K. Gündüz, C.L. Shields, J.A. Shields, J. Cater, J.E. Freire, and L.W. Brady Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement Arch. Ophthalmol. 117 1999 170 177
19. M. Decker, J.R. Castro, and D.E. Linstadt Ciliary body melanoma treated with helium particle irradiation Int. J. Radiat. Oncol. Biol. Phys. 19 1990 243 247
20. A.D. Singh, C.L. Shields, and J.A. Shields Prognostic factors in uveal melanoma Melanoma Res. 11 2001 255 263
21. S.E. Coupland, G. Anastassiou, and A. Stang The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma J. Pathol. 191 2000 120 126
22. H.M. Hurks, J.A. Metzelaar-Blok, and E.R. Barthen Expression of epidermal growth factor receptor: risk factor in uveal melanoma Invest. Ophthalmol. Vis. Sci. 41 2000 2023 2027
23. G.S. Missotten, N.E. Tang, and C.M. Korse Prognostic value of S-100-beta serum concentration in patients with uveal melanoma Arch. Ophthalmol. 121 2003 1117 1119
24. W. Li, E.S. Gragoudas, and K.M. Egan Tumor basal area ans metastatic death after proton beam irradiation for choroideal melanoma Arch. Opthalmol. 121 2003 68 72
25. Assessment of metastatic disease status at death in 435 patients with large choroideal melanoma in the Collaborative Ocular Melanoma Study (COMS). Arch Opthalmol 2001, 119, 670-676